LET’S DO THIS WITH
ZYTIGA® FIRST
(ABIRATERONE ACETATE)
ZYTIGA® (abiraterone acetate) in combination with prednisone is now indicated for the treatment of patients with metastatic high-risk castration-sensitive prostate cancer (CSPC).